487041-08-7;(5R)-3-(3-fluoro-4-iodophenyl)-5-(hydroxyMethyl)oxazolidin-2-one;856867-39-5;(R)-3-(4-(2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyl oxazolidin-2-one phosphate, disodiuM salt;Tedizolid phosphate disodiuM salt; CAS

Chinese

Company Information

Company Name:	Chengdu Miracle Chemicals Co., Ltd.
Tel:	028-85359318/15390448180
Fax:	028-85265615
Email:	sales@mic-chem.com
Nationality:	CHINA
WebSite:	www.mic-chem.com
Product List:	440

1 2 3 4 5

Product List

(5R)-3-(3-fluoro-4-iodophenyl)-5-(hydroxyMethyl)oxazolidin-2-one

(R)-3-(4-(2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyl oxazolidin-2-one phosphate, disodiuM salt;Tedizolid phosphate disodiuM salt

(R)-3-(Boc-AMino)piperidine;Alogliptin Benzoate interMediate F

(R)-3-PiperidinaMine dihydrochloride; Linagliptin interMediate D

(R)-8-(3-aMinopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione;Linagliptin API

(R) -3-(4-(2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyl oxazolidin-2-one phosphate;Tedizolid phosphate

3-{4-Methyl-3-[Methyl-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-aMino]-piperidin-1-yl}-3-oxo-propionitrile;Tofacitinib API

4-chloro-7H-pyrrolo[2,3-d]pyriMidine;Tofacitinib interMediate C

Alogliptin Benzoate; Alogliptin Benzoate API

(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;Sitagliptin

S-Linagliptin;(S)-8-(3-aMinopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione; Linagliptin iMpurity G

SS-tofacitinib;3-((3s,4s)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino) piperidin-1-yl)-3-oxopropanenitrile; Tofacitinib IMpurity A

(R)-3-(3-fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

(3R)-3-[[(2R)-Cyclopentylhydroxyphenylacetyl]oxy]-1,1-diMethylpyrrolidiniuM broMide;GlycopyrroniuM BroMide interMediate C

(R)-(-)-3-Quinuclidinol hydrochloride;Solifenacin Succinate interMediate D

(R)-(+)-3-AMinoquinuclidine dihydrochloride;Palonosetron interMediater F

(R)-1,2,3,4-Tetrahydro-1-naphthoic acid;Palonosetron interMediater C

(R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;Solifenacin Succinate interMediate G

(S)-(-)-1,2,3,4-Tetrahydro-1-naphthoic acid ;Palonosetron interMediater B

(S)-(-)-3-AMinoquinuclidine dihydrochloride;Palonosetron interMediater E

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;Solifenacin Succinate interMediate F

(S)-3-AMinopiperidine dihydrochloride;Alogliptin Benzoate interMediate B

(S)-4-(4-(DiMethylaMino)-1-(4-Fluorophenyl)-1-Hydroxybutyl)-3-(HydroxyMethyl)Benzonitrile;EscitalopraM interMediate B

(S)-Quinuclidin-3-ol;Solifenacin Succinate interMediate B

1,2,3,4-Tetrahydro-1-naphthoic acid;Palonosetron interMediater A

1-Phenyl-1,2,3,4-tetrahydroisoquinoline;Solifenacin Succinate interMediate E

2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile;Alogliptin Benzoate interMediate E

2-ChloroMethyl-4-Methoxy-3,5-diMethylpyridine hydrochloride;EsoMeprazo interMediate A

2-Cyanobenzyl broMide;Alogliptin Benzoate interMediate B

3-Quinuclidinone hydrochloride;Solifenacin Succinate interMediate A

4-[4-(DiMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)benzonitrile;EscitalopraM interMediate A

5,6,7,8-Tetrahydro-1-naphthoic acid;Palonosetron interMediater D

5-Cyanophthalide;EscitalopraM interMediate C

5-Methoxy-2-((4-Methoxy-3,5-diMethylpyridin-2-yl)Methylthio)-1H-benziMidazol;EsoMeprazo interMediate B

6-Chloro-3-Methyuracil;Alogliptin Benzoate interMediate D

Benzeneacetic acid, a-cyclopentyl-a-hydroxy-,1-Methyl-3-pyrrolidinyl ester;GlycopyrroniuM BroMide interMediate B

Diethyl D-tartrate;EsoMeprazo interMediate C

erythro-GlycopyrroniuM broMide;GlycopyrroniuM BroMide API

EscitalopraM Oxalate;EscitalopraM API

EsoMeprazole MagnesiuM

EsoMeprazole sodiuM

L(+)-Mandelic acid;EsoMeprazo interMediate D

Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate;GlycopyrroniuM BroMide interMediate A

N-(1-Azabicyalo[2,2,2]oct-3S-yl)-1,2,3,4-tetrahydronaphthalen-1S-ylcarboxaMine;Palonosetron interMediater G

Palonosetron Hydrochloride API;Palonosetron hydrochloride

R-Quinuclidin-3-ol;Solifenacin Succinate interMediate C

Solifenacin Succinate;Solifenacin Succinate API

tetraisopropoxytitaniuM;EsoMeprazo interMediate E

(S)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE

4,4,4',4',5,5,5',5'-OCTAMETHYL-2,2'-BI-1,3,2-DIOXABOROLANE

4-CHLORO-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDINE

4-Fluoro-2-Methylbenzonitrile

5-BroMo-2-pyridinecarbonitrile

Alogliptin Benzoate

Benzyl ChloroforMate

Isoquinoline-5-sulphonyl chloride hydrochloride

N-BroMosucciniMide

(2R)-1-[2-[(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)aMino]acetyl]-2-pyrrolidinecarbonitrile

(3-CarbaMoylallyl)triMethylaMMoniuM

(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine

(4-(((benzyloxy)carbonyl)aMino)-2-fluorophenyl)boronic acid;Tedizolid interMediate I

(R)-3-(3-fluorophenyl)-5-(hydroxyMethyl)oxazolidin-2-one;Tedizolid interMediate H

(R)-Glycidyl butyrate

(S)-(-)-3-(Benzoylthio)-2-Methylpropanoic acid

(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxaMide

(S)-2-(3-ethoxy-4-Methoxyphenyl)-1-(Methylsulphonyl)-eth-1-ylaMine

(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone;

1-(3-Ethoxy-4-Methoxyphenyl)-2-MethylsulfonylethylaMine

1-(5-Methoxy-1H-benzo[d]iMidazol-2-yl)-3,5-diMethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid

2-[[(5-Methoxy -1H-benziMidazol-2-yl)sulfinyl]Methyl]-3,5-diMethyl-1-4(1H)-pyridone

2-Phenylacetophenone

2-Pyrrolidinecarbonitrile, 1-(chloroacetyl)-, (2R)- (9CI)

3-[[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]pyridin-2-ylaMino]propionic acid ethyl ester

3-aMinophthalic acid

3-Ethoxy-4-Methoxybenzonitrile

5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone

5-broMo-2-(1H-tetrazol-5-yl)pyridine;Tedizolid interMediate E

5-METHOXY-2-[((4-METHOXY-3,5-DIMETHYL-1-OXIDO-2-PYRIDINYL)METHYL)SULFINYL]-BENZIMIDAZOLE

5-Methoxy-2-MercaptobenziMidazole

8-BroMo-7-but-2-ynyl-3-Methyl-1-(4-Methyl-quinazolin-2-ylMethyl)-3,7-dihydro-purine-2,6-dione;Linagliptin interMediate F

8-Methoxy-1,3-diMethyl-12-thioxo-pyrido[123,4]iMidazo[1,2-a]benziMidazol-2- (12H)-one

9-METHOXY-1,3-DIMETHYL-12-THIOXO-PYRIDO[1',2',3,4]IMIDAZO[1,2-A]BENZIMIDAZOL-2-(12H)-ONE

Deoxybenzoin OxiMe

Diphenyl phosphorochloridate

N-(1,3-dioxo-1,3-dihydroisobenzofuran-4-yl)acetaMide

OMeprazole Sulfone N-Oxide

(3R,4R)- Cis-1-benzyl-4-Methyl-3-(MethylaMino)piperidine ; Tofacitinib interMediate A

(S)-2-(3-ethoxy-4-Methoxyphenyl)-1-(Methylsulphonyl)-eth-2-ylaMine-N-acetyl-L-leucine salt

2-(ChloroMethyl)-4-Methylquinazoline; Linagliptin interMediate A

3-Phenyl-4-(4-aMinosulfonylbenzyl)-5-Methylisoxazole,Valdecoxib IMpurity A; Parecoxib SodiuM interMediate A

N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanaMide SodiuM Salt

(5R)-3-(4-broMo-3-fluorophenyl)-5-(hydroxyMethyl)oxazolidin-2-one

5-broMo-2-(2-Methyl-2H-tetrazol-5-yl)pyridine

8-BroMo-7-(2-butynyl)-3,7-dihydro-3-Methyl-1H-purine-2,6-dione; Linagliptin interMediateC

(S)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-acetylaMinoisoindoline-1,3-dione

(R)-3-(4-(2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyl oxazolidin-2-one;Tedizolid

Parecoxib SodiuM interMediate B

2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridine

3-L-pyroglutaMyl-L-thiazolidine-4-carboxylic acid;PidotiMod API

1 2 3 4 5

Copyright 2007© ChemicalBook. All rights reserved.